After six months of repeated shear stress, prostate cancer cells were induced to survive circulation-like force. CALB2 rose in those cells, but it does not appear to explain all of the resistance. doi.org/hccg9f

New mechanoresistant cancer cells show how they survive high stress environments

When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells cannot: periodic high-force moments in the vessels and heart of up to 5,000 dynes per centimeter squared as it circulates throughout the body.

medicalxpress.com

New mechanoresistant cancer cells show how they survive high stress environments Rice research team develops cancer cell lines resistant to shear force news.rice.edu/news/2026/ne... advanced.onlinelibrary.wiley.com/doi/10.1002/...

First time I’ve ever published a paper (preprint) in 8 different languages! Turns out that non-English prompts are a cheap and easy way to generate reference and hypothesis diversity in AI scientific ideation… engrxiv.org/preprint/vie...

Submit a comment using this link to the comment builder tool: takeaction.aps.org/lp/n301wnzw #AIMBE, #OMBrule, #StandUpforScience @aimbe-official.bsky.social

I am excited to give a webinar next week on the topic of “AI in Science and Research,” sponsored by the Controlled Release Society and organized by their Women in Science committee! Thank you Chiara Mancino for the invitation!

I’m excited to be a Keynote Speaker at next Monday’s Lehigh Materials Symposium! Looking forward to seeing old friends and making new ones.

Drs. Mike King (AIMBE President), Lola Eniola-Adefeso (AIMBE Immediate Past-President), and Dawn Beraud (AIMBE Executive Director) met with staff representatives from the BIOTech Caucus, as well as majority staff from the Senate Appropriations Committee… @aimbe-official.bsky.social

🌸 🏛️ AIMBE is excited to host our largest-ever Capitol Hill Day on Monday, April 13. Ahead of meetings with Members of Congress and their staff, our 130+ Fellows, Emerging Leaders, and Council Representative will convene for an advocacy breakfast. #AIMBE2026

📜 View AIMBE’s congressional talking points here: aimbe.org/wp-content/u... Thank you to the @bostonu.bsky.social Department of Biomedical Engineering for graciously sponsoring this event. #AIMBE2026

Protect U.S. Scientific Leadership and Reject FY2027 Proposed Cuts www.congressweb.com/AIMBE/12?fra... @aimbe-official.bsky.social

🚨✍️ AIMBE urges the scientific community to take a minute to send our new congressional letter opposing the President’s FY2027 budget proposal: bit.ly/420ig1A These proposed cuts to our scientific enterprise (e.g., NIH & NSF) would jeopardize training, research, and innovation driving our economy.

On Monday, AIMBE will host its largest Capitol Hill Day with >130 Fellows and advocates meeting with Members of Congress and their staff to deliver this message in person. It's essential that lawmakers also hear directly from their constituents and the broader scientific community. #AIMBE2026

Thank you to the Rice University School of Engineering and Computing and Rice University Department of Bioengineering for graciously sponsoring this event. #AIMBE2026 @profmikeking.bsky.social

🎖️ Our awards banquet hosted by AIMBE Fellow Dr. Walter Baxter will take place during our Annual Event on April 12. We will announce the recipients of the Pierre Galletti Award, AIMBE's highest honor bestowed on an individual, and our Professional Impact Awards. Join us for a celebratory evening! 🎉

A new 3D-printed platform enables efficient generation of cancer cell clusters, providing a more accurate model for studying the mechanisms behind cancer metastasis. doi.org/hbtznh

3D-printed ATLAS platform helps model cancer cell clusters behind metastasis

Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part because researchers lack reliable ways to recreate the conditions cancer cells encounter as they travel through the bloodstream.

medicalxpress.com

Great news story about our new paper in Advanced Healthcare Materials, about a new cell culture system for studying metaststic cancer… congrats to Alex Carter and team!! #OpenAccess news.rice.edu/news/2026/sc... t.co/ODQTaku8WM

act.fightcancer.org/a/tx-cprit-p... @aimbe-official.bsky.social @americancancersoc.bsky.social

🚨new GBM paper alert!🚨 What if I told you… that there was a safe, approved, BBB-accessible drug that can prime glioblastoma cells for apoptosis? #OpenAccess Fun fact: co-1st author Shanay Desai was a King Lab undergrad, now in grad studies at Penn! doi.org/10.1021/acso...

This was a super fun and insightful conversation! Thanks for joining the podcast Mike! @profmikeking.bsky.social I forgot to bring to ask you about your book!

Michael King@profmikeking.bsky.social · 5mo ago

Wake up babe, new BMES podcast just dropped! Had a great time talking about the value of professional societies with my friend @lizwaynephd.bsky.social … Liz is the best in the biz and I was honored to share my experiences with BMES… give it a listen! 🎧🎙️🗣️ www.bmes.org/podcast/offi...

Wake up babe, new BMES podcast just dropped! Had a great time talking about the value of professional societies with my friend @lizwaynephd.bsky.social … Liz is the best in the biz and I was honored to share my experiences with BMES… give it a listen! 🎧🎙️🗣️ www.bmes.org/podcast/offi...

SBIR and STTR programs lapsed on Oct. 1, 2025, halting new solicitations across federal agencies, including NIH and NSF. Delays to their restoration will disrupt the commercialization of technologies that are foundational to America's leadership in STEM innovation and economic competitiveness.

🚨 AIMBE calls on the scientific community to take a minute to send our new advocacy letter urging Congress to support the immediate reauthorization of Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) programs! Please share 👇 takeaction.io/aimbe/sbir-s...

As a Guest Editor for JoVE, I am organizing a Topical Collection titled “Techniques for the Control of Immune Cell Function Using Physical Forces.” Interested in contributing? Please submit an abstract here: app.jove.com/methods-coll...

Opinion | ‘Extraordinary and Unconstitutional’ Indeed The University of Pennsylvania is right to resist the Trump administration’s demand for lists of Jewish employees. https://bit.ly/3MhKEIl

Combining tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with focused ultrasound significantly reduces tumor size in prostate cancer models, offering a promising noninvasive treatment approach. doi.org/g85s2v

Combining protein therapy and focused ultrasound therapy can improve cancer treatment

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden in prostate cancer models, according to a new study published in Advanced Science by researchers at Rice University and Vanderbilt University.

medicalxpress.com

¿Qué pasa? 🚨new paper alert!🚨 I am excited to share our new paper, an important collaboration with Dr. Cathy Eng and VUMC: Increased prolactin levels in pregnancy affect colorectal cancer aggressiveness #OpenAccess 🧵👇 link.springer.com/article/10.1...

Pipette, mix, repeat: A reduced-order fluid model and protocol survey to evaluate 96-well mixing protocols https://www.biorxiv.org/content/10.64898/2025.12.27.696695v1

AIMBE has been busy with conferences this month! Last week, @dawnberaud.bsky.social hosted a session titled "The Importance of Advocacy in BME Research" @termisam.bsky.social which featured talks from AIMBE Fellows @cosgriffhernandez.bsky.social, @profharley.bsky.social, and Dr. Joyce Wong. (1/4)

Yesterday, Drs. Beraud and Marvin and Sarah organized a networking event during the @amsocmatbio.bsky.social Meeting in Baltimore. We were delighted to connect with nearly 20 AIMBE Fellows, Emerging Leaders, and Council Representatives over an evening of food and conversation 🍤 (2/4)

AIMBE is hosting a breakfast roundtable titled "The Importance of Advocacy in Biomedical Engineering and Medical Research" at the @amsocmatbio.bsky.social Meeting on 11/18! Join @dawnberaud.bsky.social, @jasoncmarvin.bsky.social, and our AIMBE members for this important conversation on advocacy 👇